C07C 233/72
Of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
Official title: of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
C07C233/72 (Of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings) appears on 17 US grants and 21 published applications in this corpus.
Search patents in C07C- Granted patents
- 17
- Published applications
- 21
- Assignees
- 8
- Inventors
- 49
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 2 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 4 |
| 2018 | 4 | 2 |
| 2019 | 3 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 2 | 3 |
| 2025 | 2 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof7 Oct 2025US 12,435,051 B2Vivozon Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents2 Sep 2025US 12,404,232 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents26 Nov 2024US 12,151,995 B2ModernaTX, Inc.
- Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof13 Aug 2024US 12,060,339 B2Vivozon Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents11 Jan 2022US 11,220,476 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
- Dual modulator of mglur5 and 5-ht2a receptor, and use thereof31 Oct 2024US 2024/0360092 A1Vivozon Inc.
- Covalent PPARG inverse-agonists9 May 2024US 2024/0150277 A1Bayer Aktiengesellschaft
- Compounds and compositions for intracellular delivery of therapeutic agents18 Apr 2024US 2024/0124388 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents1 Dec 2022US 2022/0380299 A1ModernaTX, Inc.
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Compounds and compositions for intracellular delivery of therapeutic agents62US 9,868,692 B2ModernaTX, Inc. · 2018
- Compounds and compositions for intracellular delivery of therapeutic agents50US 10,442,756 B2ModernaTX, Inc. · 2019
- Compounds and compositions for intracellular delivery of therapeutic agents42US 10,266,485 B2ModernaTX, Inc. · 2019
- Compounds and compositions for intracellular delivery of therapeutic agents31US 9,868,693 B2ModernaTX, Inc. · 2018